Box score
Lipella Pharmaceuticals Inc.
Reported $2.6M sold in a new Form D filed January 7, 2025 (Pittsburgh, Pennsylvania).
- Biggest raise
- $2.6M filed Jan 7, 2025
- League
- Bio & Health Pharmaceuticals
- Based in
- Pittsburgh, Pennsylvania
- Season rank
- #632 of 1,311 in the Bio & Health League; #4997 of 12,397 overall (2025)
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2025-04-01 | New notice | $9K | $9K | SEC |
| 2025-01-07 | New notice | $2.6M | $6M | SEC |
| 2024-08-15 | New notice | $120K | $120K | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1347242.
Similar raises, 2025
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Aprea Therapeutics, Inc. rookie | Bio & Health | $3.1M |
| 2 | Prolifagen, Inc. rookie | Bio & Health | $3M |
| 3 | Peca Labs, Inc. | Bio & Health | $2.7M |
| 4 | Jabez Biosciences, Inc. rookie | Bio & Health | $2.5M |
| 5 | Legacy Lyfe Holdings, LLC | Bio & Health | $2.3M |
| 6 | Respair, Inc. rookie | Bio & Health | $2.2M |